Business Description
Valeo Pharma Inc
NAICS : 325412
SIC : 3741
ISIN : CA91915B1085
Share Class Description:
TSX:VPH: Ordinary SharesCompare
Compare
Traded in other countries / regions
VPH.CanadaVP2.GermanyVPHIF.USA IPO Date
2019-02-20Description
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.1 | |||||
| Equity-to-Asset | -1.96 | |||||
| Debt-to-Equity | -1.11 | |||||
| Debt-to-EBITDA | -4.98 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -6.5 | |||||
| Beneish M-Score | -6.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 69.3 | |||||
| 3-Year EBITDA Growth Rate | -26.6 | |||||
| 3-Year EPS without NRI Growth Rate | -58.4 | |||||
| 3-Year FCF Growth Rate | -28.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 11.84 | |||||
| 9-Day RSI | 23.82 | |||||
| 14-Day RSI | 30.4 | |||||
| 3-1 Month Momentum % | -40 | |||||
| 6-1 Month Momentum % | -52.63 | |||||
| 12-1 Month Momentum % | -67.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.27 | |||||
| Quick Ratio | 0.2 | |||||
| Cash Ratio | 0.1 | |||||
| Days Inventory | 74.86 | |||||
| Days Sales Outstanding | 36.04 | |||||
| Days Payable | 71.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.5 | |||||
| Shareholder Yield % | -110.6 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.94 | |||||
| Operating Margin % | -34.61 | |||||
| Net Margin % | -60.18 | |||||
| FCF Margin % | -16.9 | |||||
| ROA % | -82.84 | |||||
| ROIC % | -43.99 | |||||
| 3-Year ROIIC % | -67.67 | |||||
| ROC (Joel Greenblatt) % | -475.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.08 | |||||
| EV-to-EBIT | -4.03 | |||||
| EV-to-EBITDA | -4.79 | |||||
| EV-to-Revenue | 1.26 | |||||
| EV-to-Forward-Revenue | 0.97 | |||||
| EV-to-FCF | -7.47 | |||||
| Price-to-GF-Value | 0.06 | |||||
| Earnings Yield (Greenblatt) % | -24.81 | |||||
| FCF Yield % | -203.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valeo Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 53.377 | ||
| EPS (TTM) (C$) | -0.34 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.98 | ||
| 3-Year Sortino Ratio | -1.22 | ||
| Volatility % | 102.97 | ||
| 14-Day RSI | 30.4 | ||
| 14-Day ATR (C$) | 0.000586 | ||
| 20-Day SMA (C$) | 0.045 | ||
| 12-1 Month Momentum % | -67.86 | ||
| 52-Week Range (C$) | 0.04 - 0.385 | ||
| Shares Outstanding (Mil) | 98.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Valeo Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valeo Pharma Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Valeo Pharma Inc Frequently Asked Questions
What is Valeo Pharma Inc(TSX:VPH)'s stock price today?
The current price of TSX:VPH is C$0.05. The 52 week high of TSX:VPH is C$0.39 and 52 week low is C$0.04.
When is next earnings date of Valeo Pharma Inc(TSX:VPH)?
The next earnings date of Valeo Pharma Inc(TSX:VPH) is .
Does Valeo Pharma Inc(TSX:VPH) pay dividends? If so, how much?
Valeo Pharma Inc(TSX:VPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers